340 related articles for article (PubMed ID: 15616241)
1. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?
Drexel H; Aczel S; Marte T; Benzer W; Langer P; Moll W; Saely CH
Diabetes Care; 2005 Jan; 28(1):101-7. PubMed ID: 15616241
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
[TBL] [Abstract][Full Text] [Related]
3. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride as a risk factor for coronary artery disease.
Gotto AM
Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
[TBL] [Abstract][Full Text] [Related]
5. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
Watanabe N; Taniguchi T; Taketoh H; Kitagawa Y; Namura H; Yoneda N; Kurimoto Y; Yamada S; Ishikawa Y
Diabetes Care; 1999 Jan; 22(1):152-6. PubMed ID: 10333918
[TBL] [Abstract][Full Text] [Related]
6. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
[TBL] [Abstract][Full Text] [Related]
7. Lipid risk factors among elderly with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitus. The Italian longitudinal study on aging.
Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G
Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):220-6. PubMed ID: 21937208
[TBL] [Abstract][Full Text] [Related]
8. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study.
Ledru F; Ducimetière P; Battaglia S; Courbon D; Beverelli F; Guize L; Guermonprez JL; Diébold B
J Am Coll Cardiol; 2001 May; 37(6):1543-50. PubMed ID: 11345363
[TBL] [Abstract][Full Text] [Related]
9. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated ldl cholesterol or by decreased hdl cholesterol?: response to Drexel et al.
Schulze MB; Hoffmann K
Diabetes Care; 2005 May; 28(5):1264; author reply 1264-5. PubMed ID: 15855613
[No Abstract] [Full Text] [Related]
10. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.
Shen Y; Chen S; Dai Y; Wang XQ; Zhang RY; Yang ZK; Hu J; Lu L; Ding FH; Shen WF
Cardiovasc Diabetol; 2019 Jun; 18(1):82. PubMed ID: 31234867
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
12. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
[TBL] [Abstract][Full Text] [Related]
13. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic values and appropriate cutoff points of lipid ratios in patients with abnormal glucose tolerance status: a cross-sectional study.
Guo W; Qin P; Lu J; Li X; Zhu W; Xu N; Wang J; Zhang Q
Lipids Health Dis; 2019 Jun; 18(1):130. PubMed ID: 31153374
[TBL] [Abstract][Full Text] [Related]
15. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
[TBL] [Abstract][Full Text] [Related]
16. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
[TBL] [Abstract][Full Text] [Related]
17. Low serum LDL cholesterol in patients with type 2 diabetes: an analysis on two different patient populations.
Saely CH; Eber B; Pfeiffer KP; Drexel H;
Int J Cardiol; 2010 Oct; 144(3):394-8. PubMed ID: 19477539
[TBL] [Abstract][Full Text] [Related]
18. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
Boizel R; Benhamou PY; Lardy B; Laporte F; Foulon T; Halimi S
Diabetes Care; 2000 Nov; 23(11):1679-85. PubMed ID: 11092292
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipid levels at diagnosis in type 2 diabetic patients.
Sosenko JM; Kato M; Soto R; Goldberg RB
Diabet Med; 1993 Nov; 10(9):814-9. PubMed ID: 8281725
[TBL] [Abstract][Full Text] [Related]
20. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes.
Liu J; Sempos C; Donahue RP; Dorn J; Trevisan M; Grundy SM
Diabetes Care; 2005 Aug; 28(8):1916-21. PubMed ID: 16043732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
